Daily Grime -IPF/ORCH

Jeremy Grime | Oct 31, 2019 11:24

This chart shows just how exceptional the value vs growth performance of the last 10 years has been. The source is Robeco.

News

Funding Circle (LON:FCH) announces a new selling tool to be launched on 2 December which is expected to enhance lenders ability to sell their loans. At the last count the queue was 124 days long

International Personal Finance PLC (LON:IPF) – Q3 Update

Share price 128p

Mkt cap £288m

Conflict Disclosure: No Holding

Update Trading is said to be “on track”. Europe credit growth is 6% while Mexico is down 12% as the company focuses on credit quality. Digital grew 3% as the company focuses on containing impairments, which ran at 43.7%. Impairments in middle of range at 27.8%. £197m headroom on facilities. The polish tax audit is concluded for 2010-2017 with earlier years now close to finalised. No further regulatory developments. Outlook is “on track”
Estimates A modest improvement in PBT to £113m is expected in 2019 which is forecast to accelerate to 11% in 2020. Digital is expected to deliver its maiden profit in 2019.
Valuation The PER is 4.5X and yield 9.8% from a modestly geared balance sheet which has a NAV of £453m, some 57% ahead of the current share price.
Conclusion With such an interesting valuation every investment bone makes me want to own this. But with the vast majority of the profits coming from Poland where the impact of the yet to be ratified rate cap and charge cap limits unclear it still remains in the “punt” camp rather than the “investment” camp. Frustrating.
Orchard Funding Group PLC (LON:ORCH) – FY Results

Share Price 76p

Mkt Cap £16m

Conflict Disclosure: Consulting Client

Results Total lending was up 6% to £72.99m in the year and the loan book was up 3.8% to £32.1m. Good lending rates drove revenue up 5.9% to £5.17m and PBT grew 6.9% to £1.89m. EPS up 8.2% to 7.08p. DPS is maintained at 3p ahead of the company investing for a banking license.

Get The App

Join the millions of people who stay on top of global financial markets with Investing.com.

Download Now

Estimates Results are ahed of expectations both at the underlying level and reported level significantly ahead by virtue of the lack of bank application costs (expected £600k)Liberum estimates assume some rate compression in 2020 but the £600k bank investment costs that were provided in 2019 are now being provided at c £1m in 2020 and so a reported PBT decline is now forecast.
Valuation The ROE is 10.9% while the shares trade very modestly above tangible book value. In PE terms that is 10.7X the number just reported with a 4% yield
Conclusion The company is entering parallel lending areas as evidenced by the investment (at no cost) made into Accolade Education Finance during the year. It may be difficult to predict the timing but with an array of other lending areas and a strategy to obtain a bank license with a strengthened board it seems very likely that the loan book growth will experience a catalyst to accelerate ahead of what are very modest forecasts. This is the highest quality loan book and when it grows fast too the valuation will be very different.

Written By: Jeremy Grime

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Show moreShow Less

Send Feedback

Privacy & Disclaimer

Follow us

© 2007-2024 Fusion Media Limited.
All Rights Reserved